Table 2.

Considerations for SARS-CoV-2 Vaccine Distribution as it Relates to Patients with IBD

Individual risk factors	Age >65 Hypertension Diabetes Obesity
IBD-related risk factors	Steroid use (probably >20 mg/d prednisone equivalent)/steroid dependence Moderately to severely active disease (possibly)
Geographic risk factors	Local/regional prevalence of COVID-19 based on test positive rate (often >8% triggers mitigation plans) or by Re (reproductive rate of the virus in the population after social distancing and other plans are activated)
Likelihood of occupational exposure to SARS-CoV-2	Patients with IBD who are health care workers, teachers, daycare workers, other essential workers

COVID-19, coronavirus disease-2019; IBD, inflammatory bowel disease; SARS-CoV-2, severe acute respiratory syndrome novel coronavirus-2.